Is BP p.l.c. (BP) a Good Option for Passive Income Investment?
An oil rig surrounded by the expanse of sea, the pumping operations in progress.
BP p.l.c. (NYSE:BP) expects the total of its dividends and share buybacks over time to be around 30% to 40% of operating cash flow. The company is targeting an increase of at least 4% per year in its ordinary dividend and announced a dividend of $0.08 per share in April. As of the writing of this piece, BP boasts an impressive annual dividend yield of 6.13%.
BP p.l.c. (NYSE:BP) also announced $750 million of share repurchases at the end of the first quarter of 2025, and the $1.75 billion share buyback program it announced with the fourth quarter results was completed on April 25, 2025.
To help improve its profitability, BP p.l.c. (NYSE:BP) has revealed that it is working on a $4 billion – $5 billion cost reduction program. The company delivered $800 million of structural cost reductions and $300 million of absolute reductions last year. Moreover, it was already $500 million lower in terms of absolute cost base in Q1 2025, compared to the same period in 2024.
BP p.l.c. (NYSE:BP) is a British multinational company recognized worldwide for quality gasoline, transport fuels, chemicals, and alternative sources of energy such as wind and biofuels.
While we acknowledge the potential of BP as an investment, we believe certain AI stocks offer greater upside potential and carry less downside risk. If you're looking for an extremely undervalued AI stock that also stands to benefit significantly from Trump-era tariffs and the onshoring trend, see our free report on the best short-term AI stock.
READ NEXT: 10 Best Nuclear Energy Stocks to Buy Right Now and The 5 Energy Stocks Billionaires are Quietly Piling Into.
Disclosure: None.
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Yahoo
19 minutes ago
- Yahoo
Barcelona forward ‘set to complete' €15m move
Barcelona on the verge of sealing their biggest sale of the summer so far, as they look to raise funds for to register new signings. Forward Pau Victor arrived for just Victor is unlikely to get much in the way of opportunites though, having played just 379 minutes under Hansi Flick this past season. With the arrival of Marcus Rashford, slated for today, Victor seems unlikely to receive much more in the way of chances next campaign, and has been left out of Barcelona's preseason tour to Japan and South Korea in order to settle his future. Offer from Braga for Pau Victor It reported that Victor had an offer on the table that he was keen to accept, but it seems the deal is much further along than previously though. The Athletic report that Victor is 'set to join' the Portuguese side, with the deal bringing in €12m for Barcelona, plus a further €3m in variables. Fabrizio Romano has added that Barcelona are negotiating to include a buyback clause in the 23-year-old's contract. Valencia drop out of race A number of clubs had been previously linked with Victor, who impressed in preseason last summer, and finished as top scorer for Barca Atletic two years ago. The most recent were Valencia, who had supposedly enquired about Victor's services. Yet RadioMarca say that due to the prospective cost of the deal, they have decided to look at other options. Los Che have not forked out such a high fee since spending €35m on Jasper Cillessen in 2019. Image viaBarcelona sales this summer Victor would be a sixth exit this summer for the Blaugrana. Clement Lenglet came to an agreement to terminate his deal before joining Atletico Madrid, while Ansu Fati and Ander Astralaga have joined AS Monaco and Granada on loan respectively. Pablo Torre has joined RCD Mallorca in a €5m deal, and Alex Valle has signed for Como in a €6m deal. Although Barcelona have benefitted from some sell-on clauses, Victor's exit would more than double their current takings.
Yahoo
19 minutes ago
- Yahoo
UK Supreme Court quashes convictions of 2 bank traders after deciding their trials were unfair
LONDON (AP) — Britain's Supreme Court on Wednesday quashed the convictions of two financial market traders accused of manipulating benchmark interest rates in one of the biggest scandals to come out of the global financial crisis in 2008. The charges against Tom Hayes, a former Citigroup and UBS trader, and Carlo Palombo, who worked for Barclays, centered around alleged efforts to influence the London Inter-Bank Offered Rate, or Libor, and its euro currency equivalent Euribor, which were used to set the interest rates on trillions of dollars of loans and other financial products around the world. The court ruled that the convictions of Hayes and Palombo were unfair because the judges in their separate cases gave inaccurate instructions to jurors. That effectively prevented jurors from considering the key question of whether the traders had acted dishonestly. 'That misdirection undermined the fairness of the trial,' Judge George Leggatt wrote in an 82-page decision backed by all five members of the panel that heard the case. Hayes was convicted in August 2015 and sentenced to a maximum of 14 years in prison, which was later reduced to 11 years. Palombo, convicted in March 2019, was sentenced to four years in prison. Both men were released in 2021. 'It destroyed my family, I missed most of my son's childhood,' Hayes told the BBC. 'For so long I've been an international fugitive … and now I can move on with my life, or try to,' he added. The decision came after the U.S. Second Circuit Court of Appeal in 2022 overturned the convictions of two traders charged with similar crimes in the United States. Hayes and Palombo, whose appeals were repeatedly rejected by British judges, were allowed to take their case to the U.K. Supreme Court after that ruling. The U.K.'s Serious Fraud Office began investigating alleged efforts to manipulate Libor in 2012. That ultimately led to the conviction of nine bankers. 'We have considered this judgment and the full circumstances carefully and determined it would not be in the public interest for us to seek a retrial,' the SFO said in response to the Supreme Court ruling. Libor and Euribor were critical benchmarks that were once used to set the interest rates on everything from business loans to home mortgages and credit card debts. As a result, they also became central to more complex financial transactions such as those used by banks and businesses to bet on interest rate fluctuations. The benchmarks were vulnerable to manipulation because they were set by banks that could profit from swings in interest rates. Each day, major international banks were asked to submit the interest rate at which they could borrow money from other banks. An average of those submissions was then used to set the daily Libor and Euribor rates. During the financial crisis, regulators became aware that some banks were making artificially low Libor submissions to make their institutions seem more creditworthy. Some traders also sought to influence the submissions made by their banks as even small moves in the benchmark rates could boost their profits. Those risks became even more pronounced during the financial crisis, when lending dried up and bankers had to base their daily submissions on a subjective assessment of the market rather than actual loans. Libor and Euribor were phased out in recent years, in part because they were seen as worsening the financial crisis. Error in retrieving data Sign in to access your portfolio Error in retrieving data Error in retrieving data Error in retrieving data Error in retrieving data
Yahoo
19 minutes ago
- Yahoo
Jim Cramer on Johnson & Johnson: 'J&J is Just Beginning Its Move'
Johnson & Johnson (NYSE:JNJ) is one of the stocks that Jim Cramer shed light on. Cramer was incredibly bullish on the company as he said: 'Now, sometimes in this game, you do just get lucky. You'll come across a surprise quarter that tells you everything you need to know about what can cause a big cap stock to rally 10 points in a session. You'll see how a star is born and even get a blueprint for what you need, what you should be looking for. Yesterday, we got a beautiful schematic from none other than Johnson & Johnson… which handed you a 10-point victory for the ages… This company put on a clinic that showed you exactly how you can orchestrate such a big gain… What does it take? Surprises, many surprises, that's what… Trong Nguyen / Johnson & Johnson (NYSE:JNJ) develops, manufactures, and sells healthcare products, including prescription treatments across areas such as immunology, oncology, neuroscience, and cardiovascular disease, along with medical technologies used in surgery, orthopaedics, cardiovascular care, and vision correction. While we acknowledge the potential of JNJ as an investment, we believe certain AI stocks offer greater upside potential and carry less downside risk. If you're looking for an extremely undervalued AI stock that also stands to benefit significantly from Trump-era tariffs and the onshoring trend, see our free report on the best short-term AI stock. READ NEXT: 30 Stocks That Should Double in 3 Years and 11 Hidden AI Stocks to Buy Right Now. Disclosure: None. This article is originally published at Insider Monkey. Error while retrieving data Sign in to access your portfolio Error while retrieving data Error while retrieving data Error while retrieving data Error while retrieving data
